← Back to Search

Imaging Technique for Head and Neck Cancer-related Lymphedema

N/A

Waitlist Available

Led By Roman Skoracki

Research Sponsored by Ohio State University Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Patients with pathologies leading to head and neck lymphedema

Patients of sound mentation, who are able to execute informed decision-making

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 24 weeks

Awards & highlights

Study Summary

This trial uses a mobile 3D scanning application to measure the head and neck region in patients with head and neck lymphedema.

Who is the study for?

This trial is for individuals with clear thinking who can make informed decisions, have minimal or no facial hair, and suffer from swelling due to lymph fluid buildup in the head and neck area. People with health issues that could affect the study or a history of not following medical advice are not eligible.Check my eligibility

What is being tested?

The trial is testing a new mobile app that uses 3D scanning to measure swelling in patients with head and neck lymphedema. This tool aims to improve how doctors diagnose lymphedema, track treatment responses, and monitor disease progression.See study design

What are the potential side effects?

Since this trial involves an imaging technique rather than medication, traditional side effects like those seen with drugs are not expected. However, there may be unforeseen risks associated with using the mobile application.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have swelling in my head or neck due to a medical condition.

Select...

I am mentally capable of making my own health decisions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 24 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 24 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Average values of the two repeated scans

Patient wellbeing/disease progression

Volume of interest between the cutting planes

Trial Design

1Treatment groups

Experimental Treatment

Group I: Screening (3D scan)Experimental Treatment1 Intervention

Patients undergo 3D scanning of lower head and neck region over 90-120 seconds before surgery and then every 3 months for up to 1 year after surgery.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Ohio State University Comprehensive Cancer CenterLead Sponsor

320 Previous Clinical Trials

290,067 Total Patients Enrolled

1 Trials studying Lymphedema

70 Patients Enrolled for Lymphedema

Roman SkorackiPrincipal InvestigatorOhio State University Comprehensive Cancer Center

Media Library

Imaging Technique Clinical Trial Eligibility Overview. Trial Name: NCT05243069 — N/A

Lymphedema Research Study Groups: Screening (3D scan)

Lymphedema Clinical Trial 2023: Imaging Technique Highlights & Side Effects. Trial Name: NCT05243069 — N/A

Imaging Technique 2023 Treatment Timeline for Medical Study. Trial Name: NCT05243069 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the enrollment stage ongoing for this research experiment?

"Per the data stored on clinicaltrials.gov, this research is not currently recruiting any participants. It was initially posted March 31st 2022 and last revised February 7th 2022. While no longer looking for volunteers, there are 469 other studies actively seeking patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Head and Neck Cancer Patient Symptom and Oncologic Outcomes

Roman Skoracki 2022. "Head and Neck Cancer Patient Symptom and Oncologic Outcomes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05243069.

All > Lymphedema